AusBiotech suggests FSANZ amend cost recovery plan

AusBiotech

21 February 2017 - AusBiotech has responded to Food Standards Australia New Zealand (FSANZ) call for comment on the draft Cost Recovery Implementation Statement (dCRIS), rejecting the proposed model to recover from industry direct and indirect costs of all FSANZ staff, and the total cost of the FSANZ Board, which are not directly involved in the specific activity in the Activity-Based Costing model used in the dCRIS.

The dCRIS provides information on how FSANZ applies cost recovery arrangements to certain applications to develop or amend food standards.

AusBiotech said it supports cost recovery where it is “justifiable, appropriate and proportionate to recovering the efficient costs of a specific government activity,” but noted that FSANZ do not have the legislative or policy authority to recover the full costs associated with all FSANZ staff.

Read AusBiotech press release

Michael Wonder

Posted by:

Michael Wonder